Review
Copyright ©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 14, 2005; 11(42): 6571-6576
Published online Nov 14, 2005. doi: 10.3748/wjg.v11.i42.6571
Immunological treatment of liver tumors
Maurizio Chiriva-Internati, Fabio Grizzi, Cynthia A Jumper, Everardo Cobos, Paul L Hermonat, Eldo E Frezza
Maurizio Chiriva-Internati, Department of Microbiology and Immunology, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, TX 79430, United States
Fabio Grizzi, Scientific Direction, Istituto Clinico Humanitas, 20089 Rozzano, and Foundation “M. Rodriguez”– Institute for Quantitative Measures in Medicine, 20100 Milan, Italy
Cynthia A Jumper, Department of Internal Medicine, Texas Tech University Health Sciences Center and Southwest Can-cer Treatment and Research Center, Lubbock, TX 79430, United States
Everardo Cobos, Department of Internal Medicine, Texas Tech University Health Sciences Center and Southwest Can-cer Treatment and Research Center, Lubbock, TX 79430, United States
Paul L Hermonat, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, United States
Eldo E Frezza, Department of Surgery, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, TX 79430, United States
Author contributions: All authors contributed equally to the work.
Correspondence to: Maurizio Chiriva-Internati, PhD, Department of Microbiology and Immunology, Texas Tech University Health Sciences Center, Room 5B191, Lubbock, TX 79430-6591, United States. maurizio.chirivainternati@ttushc.edu
Telephone: +1-806-743-4057 Fax: +1-806-743-2334
Received: January 22, 2005
Revised: February 15, 2005
Accepted: February 18, 2005
Published online: November 14, 2005
Core Tip